Session #1 – Tuesday 26 May – 16:00-17:20 BST

Paclitaxel-coated Device Consensus Update

Chairman: Roger Greenhalgh, London, United Kingdom
Moderator: Andrew Holden, Auckland, New Zealand

16:00-16:05
Podium 1st: Paclitaxel survival results related to DCBs at four years
Sapan Desai, Chicago, United States

16:05-16:10
Audience participation and discussion

16:10-16:15
Paclitaxel dose does not relate to mortality
Sabine Steiner, Leipzig, Germany

16:15-16:20
Audience participation, discussion and polling

16:20-16:25
Follow-up on the paclitaxel-late mortality signal – April 2020 update
Misti Malone, Silver Spring, United States

16:25-16:30
Audience participation, discussion and polling results

Critical limb-threatening ischaemia meta-analyses

16:30-16:35
Mortality after paclitaxel-coated device use in patients with chronic limb-threatening ischaemia: A systematic review and meta-analysis of randomised controlled trials
Ramon Varcoe, Randwick, Australia

16:35-16:40
Audience participation and discussion

16:40-16:45
New meta-analysis on DCB for critical limb-threatening ischaemia suggests increased mortality and amputation at one year
Konstantinos Katsanos, Patras, Greece

16:45-16:50
Audience participation and discussion

The value of Individual Patient Data meta-analysis

16:50-16:55
The high-impact of the VIVA IPD meta-analysis
Gary Ansel, Columbus, United States

16:55-17:00
Audience participation, discussion and polling

17:00-17:20
Industry Symposium: Endovascular treatment of complex aorto-iliac occlusive disease
Chairing: Michele Antonello, Padua, Italy

17:00-17:07
Complex occlusive iliac lesions: How to treat them
Amer Zanabili, Oviedo, Spain

17:07-17:14
Case experience
Bella Huasen, Preston, United Kingdom

17:14-17:20
Audience participation and discussion


Session #2 – Thursday 28 May – 16:00-17:20

Durability of EVAR, Sac Diameter and NICE Guidelines Consensus

Chairman: Roger Greenhalgh, London, United Kingdom
Moderator: Ian Loftus, London, United Kingdom

16:00-16:05
Consensus on the future for EVAR
Michael Jenkins, London, United Kingdom

16:05-16:10
Audience participation, discussion and polling

16:10-16:15
Ultrasound-surveillance after EVAR is feasible
Maarit Venermo, Helsinki, Finland

16:15-16:20
Audience participation and discussion

16:20-16:25
The role of the Society of Vascular Technology of Great Britain and Ireland
Lee Smith, Bolton, President of SVT, United Kingdom

16:25-16:30
Audience participation, discussion and polling results

16:30-16:35
Treatment of type II endoleaks
Lindsay Machan, Vancouver, Canada

16:35-16:40
Audience participation, discussion and polling

16:40-16:45
Contrast-enhanced duplex US for intraoperative assessment of endoleak management
Gustavo Oderich, Rochester, United States

16:45-16:50
Audience participation and discussion

16:50-16:55
Edited case: Expanding indications for aortoiliac disease – key clinical and technical learning from challenging cases
Jorge Fernández Noya, Santiago Compostela, Spain

16:55-17:00
Audience participation, discussion and polling results

17:00-17:20
Industry Symposium: Continuing the pattern of performance
Chairing: Giovanni Pratesi, Genoa, Italy

17:00-17:05
GREAT abdominal endografting questions: What does the data reveal on durability
Jan Heyligers, Tilburg, Netherlands

17:05-17:10
On label treatment of short and angulated neck: Why it matters?: Preliminary learnings from the EXCeL Registry
Giovanni Pratesi, Genoa, Italy

17:10-17:15
On label treatment of short and angulated neck: why it matters? Preliminary learnings from the BSET-CLEVAR
Colin Bicknell, London, United Kingdom

17:15-17:20
Audience participation and discussion


Session #3 – Tuesday 2 June – 16:00-17:00

Superficial Venous Disease Consensus

Chairman: Roger Greenhalgh, London, United Kingdom
Moderator: Stephen Black, London, United Kingdom

16:00-16:05
European Venous Forum guidelines on varicose veins
Armando Mansilha, Porto, Portugal

16:05-16:10
Audience participation and discussion

16:10-16:15 2020
European Society of Vascular Surgery Venous Thrombosis guidelines – implications for superficial vein thrombosis
Manj Gohel, Cambridge, United Kingdom

16:15-16:20
Audience participation and discussion

16:20-16:25
Classification and treatment of endothermal heat induced thrombosis: Recommendations from the American Venous Forum
Lowell Kabnick, New York, United States

16:25-16:30
Audience participation and discussion

16:30-16:35
Clinical assessment and work-up of patients with possible pelvic congestion syndrome
Alexsandra Jaworucka-Kaczorowska, Gorzów Wielkopolski, Poland

16:35-16:40
Audience participation and discussion

16:40-16:45
Podium 1st: Network meta-analysis comparing cyanoacrylate glue with other superficial venous therapies for chronic venous insufficiency
Raghu Kolluri, Columbus, President of ASVM, United States

16:45-16:50
Audience participation, discussion and polling

16:50-16:55
Edited case: Step by step procedure using a cyanoacrylate glue closure system
Kathleen Gibson, Bellevue, United States

16:55-17:00
Audience participation, discussion and polling results


Session #4 – Thursday 4 June – 16:00-17:20

Aortic Arch Consensus and Stroke from Thoracic Endovascular Procedures (STEP)

Chairman: Roger Greenhalgh, London, United Kingdom
Moderator: Stephan Haulon, Paris, France

16:00-16:05
Endovascular treatment for aortic arch pathologies: Chimney on-the-table fenestration and in-situ fenestration technique
Ludovic Canaud, Montpellier, France

16:05-16:10
Audience participation, discussion and polling

16:10-16:15
Options for left subclavian branch
Gustavo Oderich, Rochester, United States

16:15-16:20
Audience participation and discussion

16:20-16:25
Feasibility of endovascular arch repair post type A dissection
Kevin Mani, Uppsala, Sweden

16:25-16:30
Audience participation, discussion and polling results

16:30-16:35
Aortic arch aneurysms: Total endovascular, hybrid, open and frozen elephant trunk – which is the best and when
Roberto Chiesa, Milan, Italy

16:35-16:40
Audience participation, discussion and polling

16:40-16:45
The value of DW MRI imaging to reduce stroke – Paris and Hamburg combined arch reconstruction experience
Philippe Charbonneau, Paris/Hamburg

16:45-16:50
Audience participation and discussion

16:50-16:55
Edited case: Carotid to subclavian bypass and vascular plug subclavian endovascular occlusion before thoracic open or endovascular repair
Luca Bertoglio, Milan, Italy

16:55-17:00
Audience participation, discussion and polling results

17:00-17:20
Industry Symposium: Advancing Thoracic Care
Chairing: Ali Azizzadeh, Los Angeles, United States

17:00-17:05
When is the use of angulation control beneficial in TEVAR
Hence Verhagen, Oegstgeest, Netherlands

17:05-17:10
TEVAR in acute uncomplicated type B dissection – where are we today?
Richard Gibbs, London, United Kingdom

17:10-17:15
Is distal oversizing the sole reason for distal SINE in chronic dissection and are there device specific differences?
Santi Trimarchi, Milan, Italy

17:15-17:20
Audience participation and discussion


Session #5 – Tuesday 9 June – 16:00-17:20

Peripheral Arterial Podium 1st Session

Chairman: Roger Greenhalgh, London, United Kingdom
Moderator: Gunnar Tepe, Rosenheim, Germany

16-00-16:05
A systematic review of covered balloon-expandable stents for treating aortoiliac occlusive disease 
Jean-Paul de Vries, Groningen, Netherlands 

16:05-16:10
Audience participation and discussion

16:10-16:15
Value of a new balloon-expandable stent graft in treating challenging aortoiliac occlusive lesions – three-year results, advantages and limitations
Andrew Holden, Auckland, New Zealand

16:15-16:20
Audience participation and discussion 

16:20-16:25
Edited case: Relining of occlusive long TASC D iliac lesion 
Amer Zanabili, Oviedo, Spain

16:25-16:30
Audience participation and discussion and polling

16:30-16:35
VOYAGER: The role of rivaroxaban in PAD lower extremity revascularisation patients 
Rupert Bauersachs, Darmstadt, Germany

16:35-16:40
Audience participation and discussion and polling

16:40-16:45
MIMICS-2 study three-year results
Thomas Zeller, Bad Krozingen, Germany

16:45-16:50
Audience participation and discussion  

16:50-16:55
Podium 1st: Absence of long-term benefit revascularisation in claudicants – five-year results from the IRONIC randomised trial
Joakim Nordanstig, Molndal, Sweden

16:55-17:00
Audience participation, discussion and polling results

17:00-17:20
Industry Symposium: Overcoming the limitations of paclitaxel: A new sirolimus-coated balloon for the treatment of PVD

Chairman: Francesco Liistro, Arezzo, Italy

17:00-17:04
Prospect and appraisal of a new sirolimus-coated balloon over paclitaxel for the treatment of PAD
Aloke Finn, Gaithersburg, United States

17:04-17:10
6 months XTOSI results and rationale for randomised trials of SCB versus POBA
Edward Choke, Singapore

17:10:17:15
Outcomes of sirolimus-coated balloon in the treatment of dysfunctional AVF and AVG
Tan Chieh Suai, Singapore

17:15:17:16
Debate BTK DueIL Trials
Francesco Liistro, Arezzo, Italy

17:16:17:20
Q&A, discussion and conclusion


Session #6 – Thursday 11 June – 16:00-17:00

Vascular Access Consensus

Chairman: Nicholas Inston, Birmingham, United Kingdom
Moderator: Domenico Valenti, London, United Kingdom

16:00-16:05
Pre-operative assessment and planning
Jennifer Hanko, Belfast, United Kingdom

16:05-16:10
Audience participation and discussion

16:10-16:15
External support device to improve fistula outcomes
Robert Shahverdyan, Hamburg, Germany 

16:15-16:20
Audience participation, discussion and polling

16:20-16:25
EndoAVF technology update
Robert Jones, Birmingham, United Kingdom

16:25-16:30
Audience participation and discussion

16:30-16:35
Edited case: Endovascular creation of an arteriovenous fistula
Panagiotis Kitrou, Patras, Greece

16:35-16:40
Audience participation, discussion and polling

16:40-16:45
A new era of AV access creation and maintenance: Increasing circuit longevity with a new treatment pathway
David Kingsmore, Glasgow, United Kingdom

16:45-16:50
Audience participation and discussion

16:50-16:55
Edited case: Self-expanding covered endoprosthesis to treat failure of arteriovenous fistulas at the venous anastomosis
Matteo Tozzi, Varese, Italy

16:55-17:00
Audience participation, discussion and polling results


Session #7 – Tuesday 16 June – 16:00-17:20

Deep Venous Disease Consensus

Chairman: Armando Mansilha, Porto, Portugal
Moderator: Manj Gohel, Cambridge, United Kingdom

16:00-16:05
Designing venous stents to cope with venous anatomy: What is needed below the ligament
Christopher Cheng, Stanford, California, United States

16:05-16:10
Audience participation and discussion

16:10-16:15
Latest perspectives on the durability of deep venous stents
Erin Murphy, Charlotte, United States

16:15-16:20
Audience participation and discussion

16:20-16:25
New validated anatomic classification of chronic venous obstruction of the iliofemoral tract and its clinical implications
Houman Jalaie, Aachen, Germany

16:25-16:30
Audience participation and discussion

16:30-16:35
Consensus on essential components for delivering a deep venous service
Gerard O’Sullivan, Galway, Ireland

16:35-16:40
Audience participation and discussion

16:40-16:45
Podium 1st: Twelve-month results from the ABRE study
Stephen Black, London, United Kingdom

16:45-16:50
Audience participation, discussion and polling

16:50-16:55
Optimising patient selection in the treatment of non-thrombotic iliac vein lesions
Brian DeRubertis, Los Angeles, United States

16:55-17:00
Audience participation, discussion and polling results

17:00-17:20
Industry Symposium


Session #8 – Thursday 18 June – 16:00-17:20

Aortic Podium 1st Session

Chairman: Gustavo Oderich, Rochester, United States
Moderator: Roberto Chiesa, Milan, Italy

Abdominal Aortic

16:00-16:05
Expanding clinical experience using fibre optic technology in complex aortic repair
Tilo Kölbel, Hamburg, Germany

16:05-16:10
Audience participation and discussion and polling

16:10-16:15
ESAR in a challenging seal zone can be an effective treatment: Early mid-term results
Frank Arko, Charlotte, United States

16:15-16:20
Audience participation and discussion

16:20-16:25
Best practice with a low profile AAA stent graft in 139 patients
Eric Verhoeven, Nuremberg, Germany

16:25-16:30
Audience participation, discussion and polling results

Thoracic Aortic

16:30-16:35
Wrapping of the ascending aorta as an option for acute type A dissections
Stephan Haulon, Paris, France

16:35-16:40
Audience participation and discussion

16:40-16:45
First results from the European SURPASS registry
Giovanni Torsello, Münster, Germany

16:45-16:50
Audience participation and discussion

16:50-16:55
TBA

16:55-17:00
Audience participation and discussion

17:00-17:20
Industry Symposium


Session #9 – Tuesday 23 June – 16:00-17:00

Acute Stroke Consensus

Chairman: Hugh Markus, Cambridge, United Kingdom
Moderator: Ross Naylor, Leicester, United Kingdom

16:00-16:05
Intracranial stenting for stenosis is not dead
Andrew Clifton, London, United Kingdom

16:05-16:10
Audience participation and discussion

16:10-16:15
When operating on a carotid artery in a patient undergoing CABG the two should be done simultaneously
Barbara Rantner, Munich, Germany

16:15-16:20
Audience participation, discussion and polling

16:20-16:25
International variation in carotid surgery is huge despite all the randomised trials performed |
Maarit Venermo, Helsinki, Finland

16:25-16:30
Audience participation, discussion and polling results

16:30-16:35
Risk of cardiovascular events and death in patients with asymptomatic bilateral carotid artery stenosis: A population-based cohort study
Dominic Howard, Oxford, United Kingdom

16:35-16:40
Audience participation and discussion

Thrombectomy

16:40-16:45
Intervention in carotid artery aneurysms; indications and techniques
Gert Jan de Borst, Utrecht, Netherlands

16:45-16:50
Audience participation and discussion

16:50-16:55
Validation studies of virtual reality simulation performance metrics for mechanical thrombectomy in ischaemic stroke
Lars Lönn, Copenhagen, Denmark

16:55-17:00
Audience participation and discussion


Session #10 – Thursday 25 June – 16:00-17:00

Juxtarenal Aneurysm Consensus

Chairman: Stephan Haulon, Paris, France
Moderator: Gustavo Oderich, Rochester, United States

16:00-16:05
The advantage of inner branch technology in resolving the current challenges in fenestrated and branched solutions – large centre experience and lessons learnt
Said Abisi, London, United Kingdom

16:05-16:10
Audience participation and discussion

16:10-16:15
Edited case: Repair of a thoracoabdominal aortic aneurysm using an off the shelf endovascular graft
Bijan Modarai, London, United Kingdom

16:15-16:20
Audience participation and discussion

16:20-16:25
Single-centre experience with the new bridging stent grafts in FEVAR and BEVAR grafting
Eric Verhoeven, Nuremberg, Germany

16:25-16:30
Audience participation and discussion

16:30-16:35
Technical success and endoleaks for surgeon-modified fenestrated endografts vs. custom-made fenestrated endografts
Nikolaos Tsilimparis, Munich, Germany

16:35-16:40
Audience participation and discussion

16:40-16:45
Advantages of balloon-expandable covered bridging stents in FEVAR and BEVAR procedures: Which one is best and why
Mauro Gargiulo, Bologna, Italy

16:45-16:50
Audience participation, discussion and polling

16:50-16:55
TBA

16:55-17:00
Audience participation, discussion and polling results